Pacific Edge shares edge up
Pacific Edge’s shares jumped as much as 6.3% as investors wait for the cancer diagnostic company to reveal whether major US health insurance provider will keep using its bladder tests.
BusinessDesk
Stories written by multiple reporters.
Followers will be emailed articles by BusinessDesk